Evidence map›Paper›PMID 29164829›Full record

ArticleThe world journal of men's health2018

Prevalence of Metabolic Syndrome and Associations with Lipid Profiles in Iranian Men: A Population-Based Screening Program.

Abolfazl Mohammadbeigi, Hamid Farahani, Esmail Moshiri, Mahbobeh Sajadi, Robabeh Ahmadli, Sima Afrashteh, Salman Khazaei, Hossein Ansari

Abstract read
In one paragraph

Article in The world journal of men's health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abolfazl MohammadbeigiGastroenterology & Hepatology Disease Research Center, Qom University of Medical Sciences, Qom, Iran.ORCID https://orcid.org/0000-0002-3142-6413
Hamid FarahaniGastroenterology & Hepatology Disease Research Center, Qom University of Medical Sciences, Qom, Iran.ORCID https://orcid.org/0000-0002-1262-1854
Esmail MoshiriDepartment of Anesthesiology and Critical Care, Arak University of Medical Sciences, Arak, Iran. dr_moshiri@arakmu.ac.ir.ORCID https://orcid.org/0000-0001-9752-6559
Mahbobeh SajadiDepartment of Nursing, School of Nursing and Midwifery, Arak University of Medical Sciences, Arak, Iran.ORCID https://orcid.org/0000-0001-6770-2072
Robabeh AhmadliHealth Policy and Promotion Research Center, Qom University of Medical Sciences, Qom, Iran.ORCID https://orcid.org/0000-0001-9309-2888
Sima AfrashtehVic-Chancellor for Public Health, Bushehr University of Medical Sciences, Bushehr, Iran.ORCID https://orcid.org/0000-0002-4276-2084
Salman KhazaeiDepartment of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.ORCID https://orcid.org/0000-0001-5918-2310
Hossein AnsariHealth Promotion Research Center, Department of Epidemiology and Biostatistics, Zahedan University of Medical Sciences, Zahedan, Iran.ORCID https://orcid.org/0000-0003-2755-7864

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMetabolic syndrome (MS) is characterized by a collection of interdependent disorders, including abdominal obesity, dyslipidemia, hyperglycemia, hypertension, and diabetes. The current study aimed to estimate the prevalence of MS in Qom, Iran. MATERIALS AND

methodsA population-based screening program was conducted in the city of Qom, in 845 urban adult men over 25 years old in 2014. Abdominal obesity, fasting blood glucose (FBG), blood pressure, and the serum lipid profile were measured in subjects after fasting for at least 8 hours. MS was defined according to the Adult Treatment Panel III criteria. Data were analyzed using the chi-square test, t-test, and multiple logistic regression.

resultsThe overall prevalence of MS was 23.0%, and the most common prevalent metabolic abnormalities associated with MS were low high-density lipoprotein cholesterol (<40 mg/dL) in 34.3% of subjects, a waist circumference >102 cm in 33.9%, blood pressure ≥130/85 mmHg in 27.6%, fasting triglycerides (TG) ≥150 mg/dL in 25%, and FBG ≥110 mg/dL in 20.6%. A FBG level ≥110 mg/dL (odds ratio [OR]=4.85; 95% confidence interval [CI], 2.14~8.24), dyslipidemia (OR=3.51; 95% CI, 2.10~5.89), and a fasting TG ≥150 mg/dL were the most important factors contributing to MS.

conclusionsThe prevalence of MS in men in Qom was higher than has been reported in other countries, but it was lower than the mean values that have been reported elsewhere in Iran. FBG was the most important factor contributing to MS, and all elements of the lipid profile showed important associations with MS.

Indexed as

CholesterolHyperlipidemiasIranLipid metabolism disordersLipoproteinsPrevalence

Identifiers

PMID29164829
PMCPMC5756807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.